Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 15
Review
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,186 | Dovepress* | 5,538+ | 267 | 5,805 | |
PubMed Central* | 2,648 | 698 | 3,346 | ||
Totals | 8,186 | 965 | 9,151 | ||
*Since 16 August 2022 |
View citations on PubMed Central and Google Scholar